AG
BMRN icon

Algert Global’s BioMarin Pharmaceuticals BMRN Stock Holding History

Algert Global’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.41M Buy
166,570
+49,540
+42% +$2.89M 0.14% 222
2025
Q4 		$6.96M Buy
117,030
+76,820
+191% +$4.18M 0.11% 318
2025
Q3 		$2.18M Buy
40,210
+336
+0.8% +$19.2K 0.04% 656
2025
Q2 		$2.19M Sell
39,874
-66,004
-62% -$3.89M 0.05% 605
2025
Q1 		$7.49M Buy
105,878
+63,783
+152% +$4.29M 0.19% 152
2024
Q4 		$2.77M Buy
+42,095
New +$2.82M 0.07% 498
2023
Q4 		– Sell
-5,186
Closed -$459K – 1137
2023
Q3 		$459K Buy
+5,186
New +$461K 0.02% 769
2023
Q1 		– Sell
-4,156
Closed -$430K – 1145
2022
Q4 		$430K Buy
+4,156
New +$390K 0.02% 851

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return